Wierman ME

No ORCID on file · 4 papers in corpus · active 2004-2015

Study types

  • review 1

Condition tags

  • endometriosis 1
2015
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000000430

ObjectiveSuppression of ovarian hormones in premenopausal women on gonadotropin-releasing hormone agonist (GnRH(AG)) therapy can cause fat mass (FM) gain and fat-free mass (FFM) loss. Whether this is specifically caused by a decline in seru…

2015
Journal of applied physiology (Bethesda, Md. : 1985) ·doi:10.1152/japplphysiol.00473.2015

Suppressing sex hormones in women for 1 wk reduces resting energy expenditure (REE). The effects of more chronic suppression on REE and other components of total energy expenditure (TEE), and whether the reduction in REE is specifically due…

2013
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2012-3780

ObjectiveThe objective of the study was to evaluate the current state of clinical assays for estradiol in the context of their applications.ParticipantsThe participants were appointed by the Council of The Endocrine Society and charged with…

review 2004
Endocrine-related cancer ·doi:10.1677/erc.1.00777

Gonadotropin-releasing hormone (GnRH) is the hypothalamic factor that mediates reproductive competence. Intermittent GnRH secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and releas…